Correlation Between Exicure and HCW Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Exicure and HCW Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exicure and HCW Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exicure and HCW Biologics, you can compare the effects of market volatilities on Exicure and HCW Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exicure with a short position of HCW Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exicure and HCW Biologics.

Diversification Opportunities for Exicure and HCW Biologics

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between Exicure and HCW is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Exicure and HCW Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HCW Biologics and Exicure is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exicure are associated (or correlated) with HCW Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HCW Biologics has no effect on the direction of Exicure i.e., Exicure and HCW Biologics go up and down completely randomly.

Pair Corralation between Exicure and HCW Biologics

Given the investment horizon of 90 days Exicure is expected to generate 1.37 times less return on investment than HCW Biologics. But when comparing it to its historical volatility, Exicure is 1.51 times less risky than HCW Biologics. It trades about 0.02 of its potential returns per unit of risk. HCW Biologics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  42.00  in HCW Biologics on December 27, 2024 and sell it today you would lose (12.00) from holding HCW Biologics or give up 28.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Exicure  vs.  HCW Biologics

 Performance 
       Timeline  
Exicure 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Exicure are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Exicure reported solid returns over the last few months and may actually be approaching a breakup point.
HCW Biologics 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Exicure and HCW Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Exicure and HCW Biologics

The main advantage of trading using opposite Exicure and HCW Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exicure position performs unexpectedly, HCW Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HCW Biologics will offset losses from the drop in HCW Biologics' long position.
The idea behind Exicure and HCW Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets